Overview

• President Trump announced a government-run ‘TrumpRx’ website for consumers to buy medicines directly from manufacturers at discounted prices.
• Pfizer committed to offer Medicaid most-favored-nation pricing and to introduce new U.S. launches at reduced prices, according to Trump.
• Pfizer said it secured a three-year exemption from national-security-related tariffs as part of the arrangement.
• European pharma rallied after the news, with the Stoxx Europe 600 Health Care index up as much as 3.1% and heavyweights like Roche and AstraZeneca jumping more than 5%.
• Pfizer shares closed 6.8% higher in the U.S., and analysts said the pact could serve as a blueprint for broader industry cooperation with the administration.